Drug Discovery World

MAY 6, 2024

billion) Healthcare Innovation 2030 project, with ambitious plans to turn France into the European leader in health innovation by 2030. Since the launch of Healthcare Innovation 2030, investment has continued apace in the region. billion ($7.9 Biotechs such as ourselves and Owkin are leveraging artificial intelligence.”

Drugs 147

Drugs Science Molecular Biology Clinical Trials 147

The Pharma Data

JULY 11, 2021

Phase 3 study met primary and secondary endpoints demonstrating MenQuadfi ® induced superior immune responses to serogroup C compared to a standard-of-care vaccine in healthy toddlers MenQuadfi is the first and only quadrivalent ACWY vaccine to demonstrate superior immune response against serogroup C in toddlers.

Immune Response 52

Immune Response Disease Vaccine Licensing 52

The Pharma Data

FEBRUARY 8, 2021

District Court for the District of Delaware asserting two method of use patents (US 10,583,110 and US 10, 716,777), both of which lasts until October 2030. In Europe, where the product is commercially available in several countries and has a temporary license to be sold in France, sales were €12 million. glucosidase deficiency).

Vaccine 52

Vaccine Production FDA Pharmaceuticals 52

The Pharma Data

FEBRUARY 4, 2021

District Court for the District of Delaware asserting two method of use patents (US 10,583,110 and US 10, 716,777), both of which lasts until October 2030. In Europe, where the product is commercially available in several countries and has a temporary license to be sold in France, sales were €12 million. glucosidase deficiency).

Vaccine 52

Vaccine Production FDA Pharmaceuticals 52

The Pharma Data

APRIL 27, 2021

District Court for the District of Delaware asserting two method of use patents (US 10,583,110 and US 10, 716,777), both of which expire in October 2030. MRT5500 (SP0254), an mRNA vaccine candidate against SARS-CoV-2, entered Phase 1/2 to assess safety, immune response and reactogenicity. Interim results are expected in Q3 2021.

Vaccine 52

Vaccine Production FDA FDA Approval 52